OpGen Inc - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
OPGN Nasdaq 8071 https://opgen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OpGen Inc

OpGen Announces Acquisition of Preferred Stock by David Lazar - Mar 25th, 2024 8:05 pm
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - Nov 14th, 2023 9:30 pm
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds - Oct 12th, 2023 4:32 pm
ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories - Oct 12th, 2023 3:52 pm
OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript - Aug 13th, 2023 11:46 am
Q2 2023 OpGen Inc Earnings Call - Aug 11th, 2023 10:18 am
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update - Aug 10th, 2023 8:15 pm
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering - Aug 7th, 2023 11:30 am
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement - Aug 3rd, 2023 12:00 pm
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time - Aug 3rd, 2023 11:30 am
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND - Jul 19th, 2023 11:30 am
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe - Jun 26th, 2023 11:30 am
OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments - Jun 22nd, 2023 11:30 am
OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference - Jun 20th, 2023 11:30 am
Q1 2023 OpGen Inc Earnings Call - May 16th, 2023 10:43 am
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update - May 15th, 2023 8:15 pm
OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time - May 8th, 2023 11:30 am
OpGen Announces Closing of $3.5 Million Public Offering - May 4th, 2023 8:30 pm
OpGen Announces Pricing of $3.5 Million Public Offering - May 2nd, 2023 1:00 am
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND - Apr 26th, 2023 8:30 pm